Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 13

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Staph wars: the antibiotic pipeline strikes back

Douglas, Edward J.A., Laabei, Maisem · 2023 · Microbiology

Abstract

Antibiotic chemotherapy is widely regarded as one of the most significant medical advancements in history. However, the continued misuse of antibiotics has contributed to the rapid rise of antimicrobial resistance (AMR) globally. Staphylococcus aureus , a major human pathogen, has become synonymous with multidrug resistance and is a leading antimicrobial-resistant pathogen causing significant morbidity and mortality worldwide. This review focuses on (1) the targets of current anti-staphylococcal antibiotics and the specific mechanisms that confirm resistance; (2) an in-depth analysis of recently licensed antibiotics approved for the treatment of S. aureus infections; and (3) an examination of the pre-clinical pipeline of anti-staphylococcal compounds. In addition, we examine the molecular mechanism of action of novel antimicrobials and derivatives of existing classes of antibiotics, collate data on the emergence of resistance to new compounds and provide an overview of key data from clinical trials evaluating anti-staphylococcal compounds. We present several successful cases in the development of alternative forms of existing antibiotics that have activity against multidrug-resistant S. aureus . Pre-clinical antimicrobials show promise, but more focus and funding are required to develop novel classes of compounds that can curtail the spread of and sustainably control antimicrobial-resistant S. aureus infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1099/mic.0.001387

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 275

  1. 2019, Antibiotic resistance threats in the United States
  2. 10.1128/CMR.00134-14 · DOI · Paper page
  3. 10.3389/fimmu.2021.705360 · DOI · Paper page
  4. 10.1093/femsre/fuz030 · DOI · Paper page
  5. 10.1093/cid/ciad217 · doi:10.1093/cid/ciad217
  6. 10.1016/S0140-6736(21)02724-0 · DOI · Paper page
  7. 2019, Johns Hopkins ABX Guide
  8. 10.2217/17460913.2.3.323 · DOI · Paper page
  9. 10.2147/IDR.S173624 · DOI
  10. Moosavian, 2020, Characterization of Sccmec, SpA types and multidrug resistant of methicillin-resistant Staphylococcus aureus isolates in Ahvaz, Iran, Infect Drug Resist, 13, 1033, 10.2147/IDR.S244896 · DOI
  11. 10.1007/s10096-018-3300-0 · DOI
  12. 10.1093/jac/dkz401 · DOI
  13. 10.1038/nature17042 · DOI · Paper page
  14. 10.1016/S0140-6736(48)92166-7 · DOI · Paper page
  15. 10.1126/science.99.2579.452 · DOI · Paper page
  16. 10.5694/j.1326-5377.1955.tb35001.x · DOI
  17. 10.1172/JCI18535 · DOI · Paper page
  18. 10.1136/jcp.14.4.385 · DOI · Paper page
  19. 10.1128/AAC.44.6.1549-1555.2000 · DOI · Paper page
  20. 10.1128/jb.158.2.513-516.1984 · DOI · Paper page
  21. 10.1128/AAC.28.3.397 · DOI · Paper page
  22. 10.1128/AAC.6.6.722 · DOI
  23. 10.1042/bj1230773 · doi:10.1042/bj1230773
  24. 10.1101/cshperspect.a026989 · DOI · Paper page
  25. 10.1016/S0140-6736(97)07324-8 · DOI · Paper page
  26. 10.1126/science.1090956 · DOI · Paper page
  27. 10.1016/j.jgar.2014.04.006 · DOI
  28. 10.1128/AAC.00346-09 · DOI · Paper page
  29. 10.1016/0966-842X(96)10063-9 · DOI · Paper page
  30. 10.1016/j.jare.2019.10.005 · DOI · Paper page
  31. 10.2165/00003495-198224060-00002 · DOI
  32. 10.3109/07357909809032892 · doi:10.3109/07357909809032892
  33. 10.1592/phco.25.2.253.56956 · DOI
  34. 10.1006/jmbi.1997.0944 · DOI · Paper page
  35. 10.3389/fmicb.2018.01369 · DOI
  36. Hitchings, 2006, Inhibition of folate biosynthesis and function as a basis for chemotherapy, Adv Enzymol Relat Areas Mol Biol, 417
  37. 10.1006/jmbi.1996.0770 · DOI · Paper page
  38. 10.1128/AAC.49.9.3948-3951.2005 · DOI
  39. 10.1128/AAC.01128-08 · DOI
  40. 10.1111/j.1365-2958.1989.tb01805.x · DOI · Paper page
  41. 10.1093/jac/dkad063 · DOI
  42. 10.1016/j.bbamem.2006.02.009 · DOI · Paper page
  43. 10.1128/AAC.47.8.2538-2544.2003 · DOI · Paper page
  44. 10.1016/j.chembiol.2004.04.020 · DOI · Paper page
  45. 10.1038/s41467-020-15257-1 · DOI · Paper page
  46. 10.1371/journal.ppat.1000660 · DOI · Paper page
  47. 10.1128/mBio.01659-18 · DOI
  48. 10.1038/s41598-020-73108-x · DOI
  49. 10.1128/AAC.00970-15 · DOI
  50. 10.1128/AAC.00432-10 · DOI · Paper page
  51. 10.3389/fmicb.2022.948343 · DOI
  52. 10.1371/journal.pone.0067398 · DOI
  53. 10.1016/j.ijantimicag.2013.10.001 · DOI
  54. 10.1111/nyas.12948 · DOI · Paper page
  55. 10.1128/AAC.44.8.2160-2165.2000 · DOI
  56. 10.1038/s41598-020-80043-4 · doi:10.1038/s41598-020-80043-4
  57. 10.1128/AAC.42.5.1249 · DOI
  58. 10.1128/AAC.38.9.2014 · DOI · Paper page
  59. 10.1128/AAC.42.2.236 · doi:10.1128/aac.42.2.236
  60. 10.1128/AAC.33.9.1535 · DOI
  61. 10.1128/JB.187.7.2395-2405.2005 · DOI · Paper page
  62. 10.1128/AAC.50.3.1104-1107.2006 · DOI
  63. 10.1128/JB.184.5.1370-1377.2002 · DOI
  64. 10.1128/AAC.48.3.909-917.2004 · DOI
  65. 10.1128/AAC.01065-09 · DOI
  66. 10.1248/bpb.29.554 · DOI
  67. 10.1128/AAC.00580-10 · DOI · Paper page
  68. 10.1128/AAC.50.4.1276-1281.2006 · DOI
  69. 10.1093/jac/dkg212 · DOI
  70. 10.1128/AAC.50.1.298-309.2006 · DOI
  71. 10.1007/s10156-005-0417-8 · DOI
  72. 10.2147/IDR.S163634 · DOI
  73. 10.3389/fcimb.2019.00363 · DOI
  74. 10.1128/AAC.00398-11 · DOI
  75. 10.1093/labmed/lmw070 · doi:10.1093/labmed/lmw070
  76. 10.1073/pnas.83.16.6164 · DOI · Paper page
  77. 10.1093/jac/dkz544 · DOI
  78. 10.5812/jjm.29237 · DOI
  79. 10.2478/v10042-008-0034-3 · doi:10.2478/v10042-008-0034-3
  80. 10.1093/jac/43.2.253 · doi:10.1093/jac/43.2.253
  81. 10.2217/fmb.09.30 · DOI · Paper page
  82. 10.1093/jac/47.2.239 · doi:10.1093/jac/47.2.239
  83. 10.1128/aac.01696-22 · DOI
  84. 10.1016/S0924-8579(09)70005-6 · DOI · Paper page
  85. 10.1089/mdr.2017.0279 · DOI
  86. 10.3390/antibiotics10040398 · DOI · Paper page
  87. 10.1128/AAC.00131-06 · DOI · Paper page
  88. 10.1093/jac/dkv116 · DOI · Paper page
  89. 10.1186/s13756-020-00869-5 · doi:10.1186/s13756-020-00869-5
  90. 10.1016/s0022-2836(03)00662-4 · DOI · Paper page
  91. Westh, 1995, erm genes in erythromycin-resistant Staphylococcus aureus and coagulase-negative staphylococci, APMIS, 103, 225, 10.1111/j.1699-0463.1995.tb01099.x · doi:10.1111/j.1699-0463.1995.tb01099.x
  92. 10.3390/antibiotics10111406 · DOI · Paper page
  93. 10.1128/mBio.01975-15 · DOI · Paper page
  94. 10.1101/cshperspect.a025395 · DOI · Paper page
  95. 10.1128/AAC.02797-13 · doi:10.1128/aac.02797-13
  96. 10.1021/bi7015266 · doi:10.1021/bi7015266
  97. 10.1021/jm800038g · DOI · Paper page
  98. 10.1128/AAC.05702-11 · DOI · Paper page
  99. 10.3390/ph3071988 · DOI
  100. 10.1101/cshperspect.a027110 · DOI · Paper page
  101. 10.1128/AAC.01216-19 · DOI
  102. 10.1016/0006-291x(69)90934-6 · DOI · Paper page
  103. 10.1038/342142a0 · DOI · Paper page
  104. 10.1073/pnas.1320387110 · DOI
  105. 10.1101/cshperspect.a025437 · DOI
  106. 10.1086/499365 · DOI · Paper page
  107. 10.1038/srep19524 · DOI
  108. 10.1073/pnas.1117275109 · DOI
  109. 10.1038/nrmicro2278 · DOI · Paper page
  110. 10.1128/AAC.46.2.438-442.2002 · doi:10.1128/aac.46.2.438-442.2002
  111. 10.1128/AAC.38.5.1205 · DOI
  112. 10.1099/0022-1317-50-10-909 · doi:10.1099/0022-1317-50-10-909
  113. 10.1016/s0968-0896(03)00126-3 · DOI
  114. 10.1093/jac/dkf249 · DOI
  115. 10.1093/jac/dkq255 · DOI · Paper page
  116. 10.1093/jac/dkq255 · DOI · Paper page
  117. 10.1093/cid/cis559 · DOI
  118. 10.4137/CMRT.S1637 · DOI
  119. 10.1128/AAC.03622-14 · DOI
  120. 10.1128/AAC.01235-16 · DOI
  121. 10.1007/s40265-015-0384-z · doi:10.1007/s40265-015-0384-z
  122. 10.1128/AAC.00886-10 · doi:10.1128/aac.00886-10
  123. 10.1128/AAC.02294-20 · doi:10.1128/aac.02294-20
  124. 10.1016/j.ijantimicag.2011.03.002 · doi:10.1016/j.ijantimicag.2011.03.002
  125. 10.1093/jac/dkq375 · doi:10.1093/jac/dkq375
  126. 10.1128/AAC.02317-17 · DOI
  127. 10.1128/AAC.00078-09 · doi:10.1128/aac.00078-09
  128. 10.5772/intechopen.77863 · doi:10.5772/intechopen.77863
  129. 10.1016/j.jmii.2017.07.011 · doi:10.1016/j.jmii.2017.07.011
  130. 10.1089/mdr.2016.0021 · doi:10.1089/mdr.2016.0021
  131. 10.1089/mdr.2019.0048 · doi:10.1089/mdr.2019.0048
  132. 10.3390/antibiotics10121506 · DOI
  133. 10.2147/COPD.S90948 · DOI
  134. 10.21307/pjm-2019-007 · DOI
  135. 10.1128/AAC.47.10.3260-3269.2003 · DOI
  136. 10.1093/jac/dkh180 · DOI
  137. 10.1093/cid/ciy600 · DOI
  138. 10.1093/cid/ciy1079 · DOI
  139. 10.1128/AAC.02609-16 · doi:10.1128/aac.02609-16
  140. 10.1093/cid/ciy165 · DOI
  141. 10.1093/jac/dkx543 · DOI
  142. 10.1093/cid/ciz787 · DOI
  143. 10.2217/fmb-2017-0291 · doi:10.2217/fmb-2017-0291
  144. 10.1080/14787210.2019.1573671 · DOI
  145. 10.1128/AAC.01509-13 · DOI
  146. 10.2217/fmb-2017-0289 · doi:10.2217/fmb-2017-0289
  147. 10.2217/fmb.14.78 · doi:10.2217/fmb.14.78
  148. 10.1001/jamadermatol.2018.1103 · DOI
  149. 10.1128/AAC.00120-17 · doi:10.1128/aac.00120-17
  150. 10.1128/AAC.02169-17 · doi:10.1128/aac.02169-17
  151. Miki, 2020, Phase III double-blind comparative study of Lascufloxacin versus levofloxacin in patients with community-acquired pneumonia, Japanese J Chemother
  152. 10.1128/AAC.00120-17 · doi:10.1128/aac.00120-17
  153. 10.1358/dot.2020.56.6.3137167 · DOI
  154. 10.1093/jac/dkz493 · doi:10.1093/jac/dkz493
  155. 10.1093/jac/dkaa142 · doi:10.1093/jac/dkaa142
  156. 10.1128/AAC.01150-08 · DOI
  157. 10.1021/jm050035f · DOI
  158. 10.1128/AAC.48.9.3338-3342.2004 · DOI
  159. Bhatia, 2020, Efficacy and safety of a novel broad-spectrum anti-MRSA agent levonadifloxacin compared with linezolid for acute bacterial skin and skin structure infections: a Phase 3, openlabel, randomized study, J Assoc Physicians India, 68, 30
  160. 10.2147/DDDT.S229882 · DOI
  161. 10.1128/AAC.00641-06 · doi:10.1128/aac.00641-06
  162. 10.1007/s40265-015-0352-7 · DOI · Paper page
  163. 10.1016/j.bmc.2012.11.036 · DOI
  164. 10.1093/jac/dkv302 · DOI
  165. 10.37201/req/s01.06.2021 · doi:10.37201/req/s01.06.2021
  166. 10.1001/jama.2013.241 · DOI · Paper page
  167. 10.1016/S1473-3099(14)70737-6 · DOI · Paper page
  168. 10.1128/AAC.00663-10 · DOI
  169. 10.1093/jac/dkaa422 · DOI · Paper page
  170. 10.1128/AAC.00871-09 · DOI · Paper page
  171. 10.1124/dmd.114.061747 · DOI
  172. 10.4103/ipj.ipj_37_19 · DOI
  173. 10.1021/acs.chemrestox.0c00524 · DOI
  174. 10.1007/s40265-021-01576-0 · doi:10.1007/s40265-021-01576-0
  175. 10.3389/fmicb.2021.729900 · DOI
  176. 10.1021/jm201465w · DOI
  177. 10.1007/s10096-019-03590-3 · DOI
  178. 10.1002/phar.2366 · DOI
  179. 10.1001/jamasurg.2016.4237 · DOI · Paper page
  180. 10.1093/cid/ciy1029 · DOI · Paper page
  181. 10.1186/s12866-018-1349-7 · doi:10.1186/s12866-018-1349-7
  182. 10.3389/fmicb.2022.1043736 · DOI
  183. 10.1128/AAC.01242-13 · DOI · Paper page
  184. 10.1016/j.bmc.2016.07.029 · DOI
  185. 10.1128/AAC.01536-15 · DOI
  186. 10.1128/AAC.02488-19 · DOI
  187. 10.1093/ofid/ofx163.1413 · doi:10.1093/ofid/ofx163.1413
  188. 10.1007/s40265-018-1015-2 · doi:10.1007/s40265-018-1015-2
  189. 10.1016/S1473-3099(19)30275-0 · DOI
  190. 10.3389/fmicb.2019.02546 · DOI
  191. 10.1111/j.1749-6632.2011.06219.x · DOI
  192. 10.1101/cshperspect.a027110 · DOI · Paper page
  193. Novak, 2010, The pleuromutilin antibiotics: a new class for human use, Curr Opin Investig Drugs, 11, 182
  194. 10.1073/pnas.1517952112 · DOI
  195. 10.1128/AAC.02008-16 · DOI
  196. 10.1128/AAC.00627-16 · doi:10.1128/aac.00627-16
  197. 10.1093/jac/dks001 · doi:10.1093/jac/dks001
  198. 10.1128/AAC.05789-11 · doi:10.1128/aac.05789-11
  199. 10.1093/cid/ciz090 · DOI
  200. 10.1001/jama.2019.15468 · DOI

200 of 275 shown

Cited by

See all 13

Metadata

Authors
Douglas, E. J. A., & Laabei, M.
Venue
Microbiology
Published
2023-09-01
Volume
169
Issue
9
ISSN
  • 1350-0872
  • 1465-2080
Cited by
13
References
13
Language
en
Funders
Academy of Medical Sciences (SBF006\1023)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Staph wars: the antibiotic pipeline strikes back. https://app.cochat.ai/papers/10.1099/mic.0.001387
The paper
Douglas, E. J. A., & Laabei, M. (2023). Staph wars: the antibiotic pipeline strikes back. Microbiology. https://doi.org/10.1099/mic.0.001387

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.